Kanae Kubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kanae Kubo has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Satomi Kobayashi
Department of Medicine and Rheumatology Tokyo Metropolitan Geriatric Hospital Tokyo Japan
3 shared publications Takeshi Kusuda
Department of Medicine and Rheumatology Tokyo Metropolitan Geriatric Hospital Tokyo Japan
2 shared publications- Akiko Mano
The Department of Cardiothoracic Surgery, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
1 shared publication - Atsushi Araki
Department of Diabetes, Metabolism, and Endocrinology Tokyo Metropolitan Institute for Geriatrics and Gerontology Tokyo Japan
1 shared publication - Eiji Sunami
Department of Surgical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan
1 shared publication - Fumino Kobayashi
Tokyo Metropolitan Institute for Geriatrics and Gerontology
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e95303
Association Between Wrist-Worn Device-Estimated Sleep Efficiency and Hand Grip Strength in Older Outpatients With Cardiometabolic Diseases: Cross-Sectional Study
Background: Older outpatients with chronic diseases are susceptible to muscle weakness and functional disabilities. Recently, various wearable devices have been developed to generate health lifelogs in daily life; however, data from patients with chronic diseases remain scarce. Previous studies have shown that subjective sleep efficiency assessed by self-questionnaires is associated with grip strength, but whether objective sleep efficiency detected by wearable devices is associated with physical function and body composition remains unclear. Objective: The aim of this study is to clarify the association between sleep duration, sleep efficiency estimated by wearable watch, grip strength, frailty, and sarcopenia in outpatients with predominantly cardiometabolic diseases and the influence of diabetes as part of the Smart Watch Innovation for Geriatrics and Gerontology (SWING-Japan) project. Methods: In this cross-sectional study, the wrist-worn device Silmee 22 was used in an outpatient clinic of an acute care facility for 7‐90 nights for the analyses, and individual average sleep duration and efficiency (wearable-estimated sleep efficiency: total sleep duration/time spent in bed) were calculated. Low grip strength was defined as P =.006, 245 vs 276 min, P =.04). Wearable-estimated sleep efficiency was not associated with frailty, low muscle mass, or slow walking speed. After adjusting for the above variables, low wearable-estimated sleep efficiency, but not low sleep duration, was associated with a risk of lower grip strength (odds ratio 1.04, 95% CI 1.01‐1.08; P =.02) by 1 percentage point decrease in wearable-estimated sleep efficiency. This association was observed in patients with diabetes (odds ratio 1.05, 95% CI 1.002‐1.093; P =.04). However, no significant interaction was observed. Conclusions: In older patients with cardiometabolic diseases, objective low wearable-estimated sleep efficiency evaluated with wrist-worn wearable devices was associated with low muscle strength. No evidence was found to suggest that the strength of this association differed according to diabetes status. Longitudinal studies are needed to clarify the long-term association between low wearable-estimated sleep efficiency and muscle strength in this population.
- 9 October 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e95303
Open AccessAssociation Between Wrist-Worn Device-Estimated Sleep Efficiency and Hand Grip Strength in Older Outpatients With Cardiometabolic Diseases: Cross-Sectional Study
Background: Older outpatients with chronic diseases are susceptible to muscle weakness and functional disabilities. Recently, various wearable devices have been developed to generate health lifelogs in daily life; however, data from patients with chronic diseases remain scarce. Previous studies have shown that subjective sleep efficiency assessed by self-questionnaires is associated with grip strength, but whether objective sleep efficiency detected by wearable devices is associated with physical function and body composition remains unclear. Objective: The aim of this study is to clarify the association between sleep duration, sleep efficiency estimated by wearable watch, grip strength, frailty, and sarcopenia in outpatients with predominantly cardiometabolic diseases and the influence of diabetes as part of the Smart Watch Innovation for Geriatrics and Gerontology (SWING-Japan) project. Methods: In this cross-sectional study, the wrist-worn device Silmee 22 was used in an outpatient clinic of an acute care facility for 7‐90 nights for the analyses, and individual average sleep duration and efficiency (wearable-estimated sleep efficiency: total sleep duration/time spent in bed) were calculated. Low grip strength was defined as P =.006, 245 vs 276 min, P =.04). Wearable-estimated sleep efficiency was not associated with frailty, low muscle mass, or slow walking speed. After adjusting for the above variables, low wearable-estimated sleep efficiency, but not low sleep duration, was associated with a risk of lower grip strength (odds ratio 1.04, 95% CI 1.01‐1.08; P =.02) by 1 percentage point decrease in wearable-estimated sleep efficiency. This association was observed in patients with diabetes (odds ratio 1.05, 95% CI 1.002‐1.093; P =.04). However, no significant interaction was observed. Conclusions: In older patients with cardiometabolic diseases, objective low wearable-estimated sleep efficiency evaluated with wrist-worn wearable devices was associated with low muscle strength. No evidence was found to suggest that the strength of this association differed according to diabetes status. Longitudinal studies are needed to clarify the long-term association between low wearable-estimated sleep efficiency and muscle strength in this population.
- 11 September 2024
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 9 (1) , 104-109
Elderly-onset inflammatory myopathy associated with Sjögren’s syndrome following SARS-CoV-2 vaccination
As vaccination against SARS-CoV-2 has progressed, various autoimmune diseases, including inflammatory myopathies, have been reported to develop after vaccination. Sjögren’s syndrome (SS) sometimes presents as extra-glandular manifestations including inflammatory myopathy. In this report, we describe a case of inflammatory myopathy associated with SS that occurred in an atypically elderly patient after receiving the first dose of the SARS-CoV-2 mRNA vaccine (BNT162b2). The inflammatory myopathy was pathologically classified into non-specific myositis and characterised by predominant infiltration of the B cell lineage in this case. Combined treatment with glucocorticoid, intravenous immunoglobulin, and immunosuppressant resulted in an improvement in swallowing function and muscle strength. While we recognise the efficacy and safety of SARS-CoV-2 vaccines, we also emphasise the importance of recognising that individuals with an immunogenetic predisposition such as positivity of anti SS-A antibody may show disease activity including inflammatory myopathy following vaccination in SS, even at an atypically old age.
- 11 September 2024
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 9 (1) , 104-109
Elderly-onset inflammatory myopathy associated with Sjögren’s syndrome following SARS-CoV-2 vaccination
As vaccination against SARS-CoV-2 has progressed, various autoimmune diseases, including inflammatory myopathies, have been reported to develop after vaccination. Sjögren’s syndrome (SS) sometimes presents as extra-glandular manifestations including inflammatory myopathy. In this report, we describe a case of inflammatory myopathy associated with SS that occurred in an atypically elderly patient after receiving the first dose of the SARS-CoV-2 mRNA vaccine (BNT162b2). The inflammatory myopathy was pathologically classified into non-specific myositis and characterised by predominant infiltration of the B cell lineage in this case. Combined treatment with glucocorticoid, intravenous immunoglobulin, and immunosuppressant resulted in an improvement in swallowing function and muscle strength. While we recognise the efficacy and safety of SARS-CoV-2 vaccines, we also emphasise the importance of recognising that individuals with an immunogenetic predisposition such as positivity of anti SS-A antibody may show disease activity including inflammatory myopathy following vaccination in SS, even at an atypically old age.
- 9 January 2023
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 23 (2) , 155-156
Reply to: Comment on “influence of COVID ‐19 vaccination on disease activity of rheumatoid arthritis in older patients”
- 9 January 2023
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 23 (2) , 155-156
Reply to: Comment on “influence of COVID ‐19 vaccination on disease activity of rheumatoid arthritis in older patients”
- 5 November 2022
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 22 (12) , 1052-1054
Influence of COVID‐19 vaccination on disease activity of rheumatoid arthritis in older patients
- 5 November 2022
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 22 (12) , 1052-1054
Influence of COVID‐19 vaccination on disease activity of rheumatoid arthritis in older patients
- Open Access
- 1 January 2015
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 54 (7) , 749-753
Tracheobronchitis with Dyspnea in a Patient with Ulcerative Colitis
We herein report the case of a 42-year-old man with a one-year history of ulcerative colitis who presented with exacerbated bloody diarrhea, a productive cough and increasing breathing difficulties. Colonoscopy revealed typical deep ulcers in the rectosigmoid colon and atypical multiple sucker-like ulcers in the transverse colon, and computed tomography of the chest demonstrated wall thickening of the trachea and bronchi. In addition, bronchoscopy showed ulcers in the trachea, and histopathology disclosed findings of necrosis and inflammation of the subepithelial tissue of the trachea. Based on these findings, the patient's respiratory symptoms were strongly suspected to be due to ulcerative colitis-related tracheobronchitis. Treatment with systemic corticosteroids subsequently resulted in a rapid clinical improvement.
- 1 January 2015
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 54 (7) , 749-753
Open AccessTracheobronchitis with Dyspnea in a Patient with Ulcerative Colitis
We herein report the case of a 42-year-old man with a one-year history of ulcerative colitis who presented with exacerbated bloody diarrhea, a productive cough and increasing breathing difficulties. Colonoscopy revealed typical deep ulcers in the rectosigmoid colon and atypical multiple sucker-like ulcers in the transverse colon, and computed tomography of the chest demonstrated wall thickening of the trachea and bronchi. In addition, bronchoscopy showed ulcers in the trachea, and histopathology disclosed findings of necrosis and inflammation of the subepithelial tissue of the trachea. Based on these findings, the patient's respiratory symptoms were strongly suspected to be due to ulcerative colitis-related tracheobronchitis. Treatment with systemic corticosteroids subsequently resulted in a rapid clinical improvement.